Fusariosis in Patients With Hematologic Malignancies in the Era of Antifungal Prophylaxis
IF remains a life-threatening infection in patients with HM, often presenting as disseminated disease, despite prophylaxis. High azole MICs and the observed diversity of antifungal regimens highlight the ongoing uncertainty regarding optimal treatment and the need for prospective studies to define the role of combination therapy.
Authors
- Thomas M. Kuczmarski (ORCID: https://orcid.org/0000-0003-4936-6938)
- Leah H Yoke (ORCID: https://orcid.org/0009-0006-1756-9967)
- Pooja Bhattacharyya (ORCID: https://orcid.org/0000-0001-8524-604X)
- S. Robin Cohen (ORCID: https://orcid.org/0000-0003-2153-8486)
- Joshua A. Lieberman (ORCID: https://orcid.org/0000-0002-0376-1337)
- Regina Lengermann
- Paulina Vega
- S A Pergam
- D N Fredricks
- Hayden Z. Smith
- Lisa M. So
Institutions
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- MaineHealth (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Transplant Infectious Disease
- Published
- 2026-03-08
- DOI
- https://doi.org/10.1111/tid.70203
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00